Current advances in biomarkers for targeted therapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleisher, Brett, Clarke, Charlotte, Ait-Oudhia, Sihem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063595/
https://www.ncbi.nlm.nih.gov/pubmed/27785100
http://dx.doi.org/10.2147/BCTT.S114659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063595/
https://www.ncbi.nlm.nih.gov/pubmed/27785100
http://dx.doi.org/10.2147/BCTT.S114659

Ejemplares similares